Evan Anderson

Evan Anderson possesses extensive experience in product strategy and development within the healthcare sector. Currently serving as Mental Health Principal Product Strategy and International Product Strategy Lead at Teladoc Health since September 2020, Evan has successfully led the internationalization of domestic product lines and managed product marketing for emerging conditions, notably in the Heart Failure and Chronic Kidney Disease markets. As Founder and CEO of Luma Therapeutics, responsibilities included raising $7 million in seed funding, obtaining patents and regulatory approvals, and leading clinical trials for light therapy products. In addition, Evan co-founded Mitre Medical Corp., served as CEO for Mitral Touch, and held various roles at Spiracur, Maquet Cardiovascular, the FDA, Stanford University, and Guidant. Educational background includes advanced degrees in Biomedical Engineering from Stanford University and Case Western Reserve University, along with a Bachelor's degree from The Johns Hopkins University.